U097 The Metabolic Revolution: Training Dermatologists to be Prepared for/Incorporate/Utilize GLP-1 Agonists and Other Antidiabetics in Skin Disease
DESCRIPTION
Given the overwhelming evidence that adiposity and insulin resistance lead to an inflammatory state, addressing inflammatory diseases in dermatology without an understanding or plan to address metabolic dysfunction ultimately leads to incomplete response to treatment, unnecessary escalation of anti-inflammatory and immunosuppressive medications, and poor outcomes. We will discuss how metabolic dysfunction is recognized on physical examination, analyzed through bloodwork, and can be treated by dermatologists as part of a comprehensive therapy plan. Further, dermatologists are often the only opportunity for recognition and diagnosis of metabolic dysfunction so additional referral recommendations and nutrition/lifestyle counseling will be discussed.
LEARNING OBJECTIVES
Demonstrate to role of adiposity and insulin resistance in inflammatory conditions including acne, hidradenitis suppurativa, psoriasis, cicatricial alopecia, atopic dermatitis, and urticaria.
Identify metabolic dysfunction clinically and by analysis of bloodwork to determine if this needs to be addressed as part of a holistic approach to their inflammatory condition.
Discuss treatment options and lifestyle modifications that dermatologists can use with standard therapies to improve patient outcome in the inflammatory conditions discussed.
SCHEDULE
7:30 AM
The metabolic disease state and intervention with GLP-1 receptor agonist
Lindsey Bordone, MD, FAAD
7:54 AM
Metabolic influences on hidradenitis suppurativa
Ginette Okoye, MD, FAAD
8:06 AM
Dietary influences on the gut microbiome and metabolic function
Tamia A Harris-Tryon, MD, PhD, FAAD
DIRECTOR
Lindsey Bordone, MD, FAAD
SPEAKERS
Tamia A Harris-Tryon, MD, PhD, FAAD
Ginette Okoye, MD, FAAD
DISCLOSURES
Lindsey Bordone, MD, FAAD
No financial relationships exist with ineligible companies.
Tamia A Harris-Tryon, MD, PhD, FAAD
Burroughs Wellcome Fund – Other(Grants/Research Funding); Keystone Symposia – Other(No Compensation Received); Mirofend – Founder(No Compensation Received);
Ginette Okoye, MD, FAAD
AbbVie – Advisory Board(Honoraria); Janssen Pharmaceuticals, Inc – Consultant(Honoraria), Investigator(Residency/Fellowship Program Funding); Nutrafol – Advisory Board(Honoraria); Sanofi Regeneron – Advisory Board(Honoraria); UCB – Advisory Board(Honoraria); Unilever – Consultant(Honoraria);